We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$4.08B
1-Year Est. Return
58.77%
This Fund
S&P 500
This Quarter
Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
(-57%)
Cap. Flow
-$4.51B
Cap. Flow
% of AUM
-101.07%
Top 10 Holdings %
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$41.1M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
+$25.3M |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$18.4M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$15.7M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$15.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$411M |
| 2 |
Microsoft
MSFT
|
+$372M |
| 3 |
Amazon
AMZN
|
+$192M |
| 4 |
Tesla
TSLA
|
+$121M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.54% |
| 2 | Healthcare | 10.8% |
| 3 | Consumer Discretionary | 9.19% |
| 4 | Financials | 8.28% |
| 5 | Communication Services | 7.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4651
Astrotech Corp
ASTC
$17.9M
| $8K | ﹤0.01% |
582
+319
| +121% | +$5.15K |
|
4652
Autohome
ATHM
$2.6B
| $8K | ﹤0.01% |
194
-16,798
| -99% | -$523K |
|
4653
Aveanna Healthcare
AVAH
$2.46B
| $8K | ﹤0.01% |
3,787
+1,295
| +52% | +$3.75K |
|
|
JBIO
4654
Jade Biosciences
JBIO
$1.51B
| $8K | ﹤0.01% |
15
-26
| -63% | -$12.4K |
|
4655
Banco de Chile
BCH
$20.5B
| $8K | ﹤0.01% |
464
+74
| +19% | +$1.5K |
|
4656
Biomerica
BMRA
$5.01M
| $8K | ﹤0.01% |
346
+182
| +111% | +$5.2K |
|
4657
BRC Inc
BRCC
$212M
| $8K | ﹤0.01% |
+1,007
| New | +$13.8K |
|
4658
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$89.2M
| $8K | ﹤0.01% |
+118
| New | +$10.8K |
|
|
STEX
4659
Streamex Corp
STEX
$90.3M
| $8K | ﹤0.01% |
1,222
+996
| +441% | +$9.36K |
|
4660
Cemtrex
CETX
$5.2M
| – | – |
0
| – | – |
|
4661
CleanSpark
CLSK
$2.96B
| $8K | ﹤0.01% |
2,027
-1,524
| -43% | -$10.3K |
|
4662
CNS Pharmaceuticals
CNSP
$7.53M
| – | – |
0
| – | – |
|
4663
Cosmos Holdings
COSM
$12.8M
| $8K | ﹤0.01% |
+867
| New | +$21.9K |
|
4664
Contango Silver & Gold Inc
CTGO
$653M
| $8K | ﹤0.01% |
343
-180
| -34% | -$4.23K |
|
4665
Cyclerion Therapeutics
CYCN
$18.3M
| $8K | ﹤0.01% |
678
-195
| -22% | -$2.79K |
|
4666
Endava
DAVA
$167M
| $8K | ﹤0.01% |
90
-158
| -64% | -$16.5K |
|
4667
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.98B
| $8K | ﹤0.01% |
218
-3
| -1% | -$122 |
|
4668
Journey Medical
DERM
$183M
| $8K | ﹤0.01% |
2,035
-119
| -6% | -$471 |
|
4669
Donegal Group Class A
DGICA
$696M
| $8K | ﹤0.01% |
493
-471
| -49% | -$7.06K |
|
4670
1stdibs.com
DIBS
$163M
| $8K | ﹤0.01% |
1,407
+385
| +38% | +$2.53K |
|
4671
Data Storage Corp
DTST
$8.37M
| $8K | ﹤0.01% |
3,290
+3,216
| +4,346% | +$9.19K |
|
|
ELEV
4672
DELISTED
Elevation Oncology
ELEV
| $8K | ﹤0.01% |
5,382
+3,327
| +162% | +$8.35K |
|
|
EVOK
4673
DELISTED
Evoke Pharma
EVOK
| $8K | ﹤0.01% |
200
+125
| +167% | +$5.96K |
|
4674
GH Research
GHRS
$1.94B
| $8K | ﹤0.01% |
+897
| New | +$11.7K |
|
|
GRI
4675
GRI Bio
GRI
$3.13M
| – | – |
0
| – | – |
|
Similar funds
CA
ICP
AP
BWA
JSW
SP
GCM
ZP
Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review
As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.
- Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
- Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
- Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
- Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
- Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
- Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
- Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.